Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00033215 · ClinicalTrials.gov registry record · Phase 1
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 study, sponsored by Shionogi.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT00033215 is a Phase 1 study that has completed, run by Shionogi. The registered enrollment target is 32 participants.
The verdict
NCT00033215, a Phase 1 study, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy accessible cancer who have failed previous therapy or to whom no standard therapies are available. To determine the pharmacokinetic profile of S-3304 in this patient population
Interventions
- DRUG S-3304
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2001-11 |
| Est. Completion | 2003-03-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00033215
The ClinicalTrials.gov registry entry for NCT00033215 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which S-3304 is the first listed.
NCT00033215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00033215 about?
NCT00033215 is a clinical study titled "A Phase 1 Study of S-3304 in Patients With Solid Tumors". To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy accessible cancer who have failed previous therapy or to whom no standard therapies are available. To determine the pharmacokinetic profile of S-3304 in this patient population
What is the current status of trial NCT00033215?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2001-11. Estimated completion is 2003-03-12.
What interventions are being tested in trial NCT00033215?
The interventions under investigation include: S-3304 (DRUG).
Who is sponsoring clinical trial NCT00033215?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.